Nova Eye Medical (AU:EYE) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nova Eye Medical Limited has announced changes in the securities interests of its director, Thomas Anthony Spurling. The director’s direct and indirect holdings have increased following the lapse of 700,000 options. This update may influence investor sentiments as it reflects a shift in insider holdings.
For further insights into AU:EYE stock, check out TipRanks’ Stock Analysis page.